Biolase Technology, Inc.
418 articles with Biolase Technology, Inc.
BIOLASE to Participate at Dougherty & Company Institutional Investor Conference on September 5, 2019
President and CEO Todd Norbe and Executive Vice President and CFO John Beaver will hold one-on-one and small group meetings with institutional investors throughout the day.
BIOLASE, Inc. reported net revenue of $8.7 million for the second quarter ended June 30, 2019, a decrease of 29% compared to the second quarter of 2018.
BIOLASE, Inc. announced that it will release second quarter 2019 financial and operating results on Thursday, August 8, 2019 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.
Hear from leading experts, including keynote speaker Gordon J. Christensen DDS, MSD, PhD, on the latest trends and innovations in dentistry [16-May-2019] IRVINE, Calif. , May 16, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, is proud to announce that it will host the Advancing Dentistry Symposium in San Diego, California
BIOLASE, Inc. reported net revenue of $10.3 million for the first quarter ended March 31, 2019, an increase of 3% compared to the first quarter of 2018.
BIOLASE, Inc. announced that it will release first quarter 2019 financial and operating results on Thursday, May 9, 2019 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.
BIOLASE and TeamSmile Expand Initiative of Oral Health Day to Students in Kansas City Public Schools
Players and mascot "Blue the Dog" from Sporting Kansas City will be in attendance to meet and greet the students and support the program
BIOLASE, TeamSmile and Los Angeles Chargers to Host Oral Health Fair for Students from Los Angeles Public Schools
Chargers wide receiver Geremy Davis, running back Justin Jackson and the Charger Girls to meet the students and support necessary cause
BIOLASE, Inc., the global leader in dental lasers, announced that it will be presenting at the second annual LD Micro Virtual Investor Conference on Wednesday, March 13th at 10:40 am PT.
BIOLASE, Inc., the global leader in dental lasers, reported net revenue of $13.0 million and $46.2 million for the fourth quarter and year ended December 31, 2018, respectively.
BIOLASE appoints Sinclair Dental, the fastest growing full-service dental supply company in Canada, as the exclusive distributor and representative for the sales, service and support of BIOLASE's products
BIOLASE, Inc. announced that it will release fourth quarter 2018 financial and operating results on Tuesday, March 5, 2019 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to present at the following two investor conferences in December.
BIOLASE, Inc. today announced that it will release third quarter 2018 financial and operating results on Monday, November 12, 2018.
BIOLASE and Los Angeles Chargers Host TeamSmile Event to Increase Access to Oral Health for Children in Underserved Communities
Players and cheerleaders from the LA Chargers will be at the event to greet the children as they're offered free dental care
Southern California Market Initiative Showing Early Signs of Success as Core Laser Revenue in the Region Increased Almost 200% from Prior-Year Quarter
John R. Beaver Promoted to Executive Vice President and Chief Financial Officer
BIOLASE, Inc. announced that the Company will host a conference call on Wednesday, August 8, 2018, at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter ended June 30, 2018, and to answer questions.
BIOLASE, Inc. that it has appointed veteran senior dental industry executive, Todd A. Norbe and veteran senior finance executive Jess Roper to its Board of Directors, effective immediately.
BIOLASE, Inc. announced that it has received a letter from Nasdaq Listing Qualifications confirming that the Company has regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market.